Moreover, our initial goal to find drugs that could prevent invasion of HER2 inhibition resistant cancer models while retaining most of the activity of cathepsin B and thus the cell’s ability to undergo lysosome-dependent cell death was achieved. Here, ERBB2 is linked to cancer.